RPTECH NSE filing

RPTECH Q1 FY26 Net Profit Rises, Board Approves ₹2 Dividend & Key Director Re-appointments

The RealCase readMedium impact Neutral

Why it matters

The announcement includes the latest financial performance, a dividend recommendation for shareholders, and re-appointments of key whole-time directors and continuation of an independent director, which collectively are significant for the company's operations and investor returns.

The market read

While the company reported an increase in standalone and consolidated profit after tax for the quarter ended June 30, 2025, revenue from operations significantly decreased year-on-year. The dividend recommendation is positive, but it is for the previous fiscal year and subject to shareholder approval.

Rashi Peripherals Limited announced the outcome of its Board Meeting held on 5 August 2025, approving several key decisions: * Financial Results (Quarter ended 30 June 2025): * Standalone: Revenue from operations was ₹3,052.73 crore (₹30,527.27 million), with a profit after tax of ₹58.83 crore (₹588.25 million). Basic EPS stood at ₹8.93. * Consolidated: Revenue from operations was ₹3,152.14 crore (₹31,521.43 million), with a profit after tax of ₹61.70 crore (₹617.00 million). Basic EPS was ₹9.30. * Compared to the quarter ended 30 June 2024, revenue from operations decreased significantly, but profit after tax increased for both standalone and consolidated results. * The company recorded a net loss of ₹0.0005 crore (₹0.05 million) from selling its 51% stake in Znet Technologies Private Limited in standalone results, while a gain of ₹3.01 crore (₹30.14 million) was recognized in consolidated results from the loss of control in the same subsidiary. * Annual General Meeting (AGM): The 36th AGM is approved to be held on Tuesday, 9 September 2025, at 11:00 a.m. (IST) via Video Conferencing or Other Audio Visual Means. * Dividend Recommendation: The Board had recommended a dividend of ₹2/- per equity share (face value ₹5/- each) for the financial year ended 31 March 2025. This is subject to shareholder approval at the upcoming AGM. The Record Date for determining dividend entitlement is Monday, 11 August 2025, with payment/dispatch within 30 days from the AGM approval date. * Board Re-appointments: * Mr. Krishna Kumar Choudhary was approved for re-appointment as Chairman & Whole-Time Director for five years, from 1 October 2025 to 30 September 2030. * Mr. Sureshkumar Pansari was approved for re-appointment as Vice-Chairman & Whole-Time Director for five years, from 1 October 2025 to 30 September 2030. * The continuation of Mr. Yazdi Dandiwala's term as an Independent Director was approved, despite him attaining 75 years of age, for his remaining tenure until 28 July 2027. * All re-appointments/continuation are subject to shareholder approval at the AGM. * IPO Proceeds Utilization: As of 30 June 2025, the company utilized ₹548.61 crore (₹5,486.13 million) out of the net IPO proceeds of ₹554.14 crore (₹5,541.41 million), with ₹5.53 crore (₹55.28 million) remaining unutilized for general corporate purposes. The Monitoring Agency Report confirmed nil deviation from the objects of the IPO.

Filing to action

What to do with a filing like this

Rashi Peripherals Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Rashi Peripherals Limited. Read the original for the full detail.

View original filing